The market for cold disposable biopsy forceps is constrained to single-use endoscopic instruments of tissues applied during gastrointestinal (GI), pulmonary, and urological methods for the removal of the tissues. This makes electrocautery redundant and minimizes thermal damage to surrounding tissues.
The growing prevalence of gastrointestinal disorders, increasing adoption of minimally-invasive diagnostic procedures, and growing focus on infection control measures during endoscopic procedures are expected to drive the growth of the global endoscopy market. In addition, constant advancements in the biopsy forceps designs, like improved precision and patient well-being capabilities, are also augmenting the growth of the market.
In 2025, the global cold disposable biopsy forceps market is projected to reach approximately USD 742.9 million, with expectations to grow to around USD 1,574.4 million by 2035, reflecting a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
The associated increase in demand for single-use medical devices to prevent cross-contamination, an increase in the number of endoscopic biopsy procedures performed for early diagnosis of cancer diseases, and a growing healthcare infrastructure in developing economies contribute to the projected compound annual growth rate (CAGR). Regulatory guidelines favour disposable biopsy forceps eying infection control, benefitting disposables, which is expected to drive the market growth.
Explore FMI!
Book a free demo
North America is anticipated to continue its hold in the global cold single-use biopsy forceps market and, at the same time, register as the most lucrative cold single-use biopsy forceps market during the forecast period. However, the growing use of the non-communicative endoscopes is expected to act as an industry pain point in the future. It is estimated to be one of the restraining factors to the growth of the ERCP Market. Another driving factor for the growth of the market is increasing awareness about early diagnosis of cancer and preventive diagnostics.
The European continent is accompanied by the market owing to the development of gastrointestinal and respiratory endoscopic procedures in Germany, France, and the UK. The new European Union (EU) medical device regulation (MDR) implemented in May 2021, you can see this trend only continuing; there is a real requirement for manufacturers of such medical devices, both large and small scale, to consider the patient and the prevention of infection from the outset.
This is attributed to the substantial investments being made for endoscopic technologies in the region, along with government initiatives that are enhancing access to healthcare and making it more affordable, thereby promoting market proliferation. Moreover, as the awareness regarding infection control grows in hospitals, disposable medical instruments are preferred over reusable medical instruments.
Challenges
High Initial Costs and Limited Awareness in Emerging Markets
The challenges of the high-pressure processing equipment market are high capital investments and low market penetration in developing areas. In spite of the superiority over surface modification, sterilization, and wound healing, the non-standardization of cold plasma technologies and lack of awareness among end-users limit the large-scale utilization of the practices. Moreover, stringent regulatory clearances, as well in healthcare and food safety applications, impose compliance barriers on the manufacturers.
Opportunity
Expansion in Healthcare, Sterilization, and Sustainable Industrial Applications
Due to its characteristics, such as antimicrobial properties, non-thermal effects on products, and eco-friendly aspects, cold plasma is under development for many usages in medical applications, food processing, and industrial surface modifications. They are esteemed for non-invasive, chemical-free, and cost-effective procedures, which results in the rising demand for cold plasma, thus increasing market revenues for wound healing, cancer therapies, and medical device sterilization. Moreover, its usage in textile finishing, semiconductor manufacturing, and sustainable agriculture presents fresh growth possibilities.
Due to their chemical-free disinfection capabilities, cold plasma technologies emerged as a promising solution for medical sterilization, textile treatment, and food decontamination between 2020 and 2024. However, high costs, limited awareness, and slow regulatory approvals hampered wider adoption in developing regions.
By 2025 to 2035, the use of cold plasma in medical treatments, wearable electronics and sustainable packaging is expected to become common on the market. Market penetration and regulatory acceptance will further increase with advances in portable cold plasma devices, AI engine-based automatic plasma control, and eco-friendly plasma processing technologies.
Market Shifts: A Comparative Analysis 2020 to 2024 vs. 2025 to 2035
| Market Shift | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | Compliance with medical device sterilization and food safety regulations |
| Technology Innovations | Development of cold plasma sterilization and surface modification techniques |
| Market Adoption | Growth in textile treatment, food decontamination, and electronics surface modifications |
| Sustainability Trends | Initial applications in chemical-free sterilization and industrial coatings |
| Market Competition | Dominated by plasma technology providers and medical device firms |
| Consumer Trends | Increased demand for chemical-free sterilization and food safety solutions |
| Regulatory Landscape | Compliance with medical device sterilization and food safety regulations |
| Market Shift | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | Stricter regulations on plasma-based therapies, eco-friendly industrial applications, and plasma sterilization in healthcare |
| Technology Innovations | Advancements in portable, AI-integrated cold plasma systems for healthcare, food, and electronics |
| Market Adoption | Expansion into wound healing, cancer therapy, wearable electronics, and sustainable packaging |
| Sustainability Trends | Large-scale adoption of plasma-based sustainable processing in textiles, agriculture, and waste treatment |
| Market Competition | Rise of startups focusing on cold plasma-based regenerative medicine and green energy applications |
| Consumer Trends | Growth in plasma-based medical therapies, cosmetic treatments, and eco-friendly industrial applications |
| Regulatory Landscape | Stricter regulations on plasma-based therapies, eco-friendly industrial applications, and plasma sterilization in healthcare |
The growth of various end-user industries such as logistics, automotive, and retail sectors is driving the demand for United States collaborate sleeve containers, as the end-user industries are adopting collapsible sleeve containers to save on cost and optimize product handling in bulk. Growing emphasis on supply chain optimization and the use of reusable packaging solutions is driving market growth.
The presence of dominant e-commerce companies and strict sustainability regulations are spurring companies to adopt collapsible sleeve containers for minimization of packaging waste and boosting operational efficiency. Moreover, the introduction of innovative materials that are durable and lightweight is complementing the penetration of such containers in the USA.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 4.2% |
The demand for the UK collapsible sleeve containers market is being boosted by a heightened focus on sustainable efficient, cost-effective packaging solutions. With growing pressures from environmental regulations and the need to minimize the generation of plastic waste, reusable bulk containers are quickly being adopted by the logistics and retail industries.
Collapsible sleeve containers are also witnessing increased demand due to the growth in e-commerce and the rising need for efficient warehouse management. Moreover, the transition towards returnable and reusable packaging solutions is accelerated by the push toward circular economy initiatives and government-backed sustainability programs.
Additionally, the growing food and beverage industry, which needs hygienic and space-efficient bulk packaging, also assists market growth.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 3.7% |
Key drivers of the European Union (EU) 's Collapsible Sleeve Containers Market Growth include stringent sustainability regulations, the implementation of reusable packaging, and the development of border trade in Europe. The EU’s intent to tackle single-use plastic is pushing businesses to move towards collapsible sleeve containers as an environmentally friendly solution.
Rampant awareness regarding the adoption of sustainable bulk packaging solutions, especially in the automotive, pharmaceutical, and industrial sectors, is supporting the growth of the market in Germany, France, and Italy. A strong presence of third-party logistics (3PL) providers using returnable transit packaging is also contributing to the market growth.
Moreover, advancements in lightweight and recyclable materials in sleeve containers can make them cost-efficient and durable for supply chain operations.
| Country | CAGR (2025 to 2035) |
|---|---|
| EU | 3.6% |
Increasing priorities of automation in Japan, as well as the need for space optimization and sustainable packaging across the region, are likely to build the Japan collapsible sleeve containers market. The market is being propelled by the increasing use of returnable packaging solutions in the automotive and electronics industries.
With a robust logistics infrastructure and stringent waste management policies, Japan is promoting the use of collapsible sleeve containers for efficient and sustainable material handling. Moreover, the rising demand for space-efficient and collapsible warehousing solutions in urban distribution hubs is fostering market expansion.
Japan’s expanding retail and e-commerce industry is also supporting the increasing adoption of collapsible packaging for warehouse and in-transit storage applications.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 3.9% |
The market for collapsible sleeve containers in South Korea is still on the rise, propelled by the growth of the manufacturing, automotive, and logistics industries. A growing emphasis on sustainable packaging solutions in the country, as well as the rising use of smart logistics practices, are driving the demand for collapsible bulk containers.
Government mandates that promote waste prevention and circular economy practices are incentivizing companies to adopt reusable and returnable packaging solutions. Furthermore, the e-commerce industry in South Korea is burgeoning, along with the need for space-saving solutions for warehouse management, which is further accelerating the growth of the market.
The rise of the hygienic and lightweight packaging also in food and pharmaceutical sections, so this is also the factor which drives the collapsible sleeve container market.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 3.8% |
The cold disposable biopsy forceps market has a growing trend of use of oval cup biopsy forceps as the device of choice in the market due to their accuracy and efficacy in tissue sampling. These nondramatic forceps have a smooth, rounded cup design to minimize traumatic injury to surrounding tissues while still allowing sufficient biopsy material to be obtained. Synchronously used by physicians in GI endoscopic procedures, pulmonology biopsy, and urology applications, the oval cup biopsy forceps is a popular tool as it makes it possible to obtain quality histological specimens.
This is expected to increase the use of oval cup biopsy forceps, which would ultimately contribute towards the growth of the oval cup biopsy forceps market. Their utility in procuring tissue specimens from the upper as well as lower gastrointestinal tract, bronchi, urological structures, etc., has only cemented the foothold in the market. This process continues with cup design innovations helping manufacturers create cups that provide better cutting efficiency and lower surgery complications.
Although those forceps work great for getting biopsies, they're not economical for healthcare systems since they are used only once. Nonetheless, a growing focus on infection control and regulatory guidelines that increasingly favour disposable medical devices has nudged acceptance of cold disposable oval cup biopsy forceps. The irrefutable fact that GI disorders and pulmonary conditions are on the rise is predicted to contribute significantly towards boosting the largest share of this market segment in the ensuing years, resulting in a spur in technological advancements for the products, with factors like higher investment and expertise involved in these devices, which will continue to be inevitable through the years.
Due to their high grip quality, alligator jaw biopsy forceps have also been used as a complementary device for biopsy from deep or fibrotic tissues. Whereas oval cup forceps work by offering a smooth gripping surface for the retrieval of tissue, alligator jaw forceps have serrated edges on their jaws to help with the capture of tissue and greatly reduce the likelihood that tissue will slip from the jaws during procedures. Such biopsies are particularly useful in sampling lesions comprised of fibrous or dense tissue.
This increased tissue engagement improves biopsy yields, therefore alligator jaw biopsy forceps are desired by gastroenterologists, pulmonologists, and otolaryngologists for use in a variety of procedures. Advances in technology in flexible endoscopy and interventional pulmonology have accelerated the demand for alligator jaw forceps used to obtain tissue from the bronchial tree and esophageal strictures.
Alligator jaw biopsy forceps provide more grip and biopsy yield; however, the serrated edges can inflict further crush injury in the more fragile anatomical zones. Manufacturers circumvent this issue by optimizing design edges that trade off delivery efficiency and patient safety, considering the volume of any damageable sample. As biopsy techniques continue to evolve, alligator jaws' biopsy forceps are becoming increasingly popular, particularly for complex endoscopic procedures requiring a firm hold on tissue.
The 1.8mm biopsy forceps segment has captureda significant share in the cold disposable biopsy forceps market attributed to its compatibility with standard & ultra-thin endoscopes. An example of a common BI-OR® bioptome would be stainless steel biopsy forceps which are commonly used in all diagnostic and therapeutic indications in gastroenterology, pulmonology and urology and to take samples of tissues for diagnosis and treatment.
The working statement technologies are, e.g., it is known that with the addition of 300, the distal tip of an embodiment of the normal ear, there 0.8 is no longer significant. However, these would indicate that. the average body still, ultimately, the base of the material must be small to touch the conductor (touch, etc.) soft needle at a sensed Distance of 0.75 within, there are often droplets contained; they only be laid for observation, are opaque, and ripe via a time means the measurement. Being smaller, though still generating high-quality biopsy targets, means they can navigate fine anatomical structures in a less invasive manner, leading to a reduction in patient discomfort. Additionally, their disposability reduces the risk of cross-contamination, aligning with sterilization practices in clinical settings.
Rising cases of gastrointestinal cancers, pulmonary disorders, and Barrett’s esophagus have been driving demand for minimally invasive biopsy instruments, hence leading to a revenue upsurge of 1.8 mm biopsy forceps. Manufacturers are constantly upgrading the ranges that are used in diagnostic applications by reinventing the design of forceps using sophisticated metallurgy and ergonomic handles.
Clinicians use 2.4mm Forceps for upper and lower GI endoscopic biopsies, where deeper tissue samples are indicated for histopathological studies. Their larger diameter compared to needle biopsies improves the adequacy of the samples, therefore decreasing the need for repeat biopsies, making them more diagnostically efficient. The demand for these forceps in routine and specialized biopsy procedures has increased due to a rising emphasis on early cancer detection, as well as precision diagnostics.
Larger-diameter biopsy forceps can also capture pieces of larger tissues, but they need scope with wider working channels, which prevents the ultra-thin scopes from using them. The increased adoption of larger working channel endoscopes in tertiary-managed healthcare facilities supporting the evolution of endoscopic technology is expected to support the demand for the 2.4mm biopsy forceps segment. The demand for multifunctional, high-precision biopsy forceps will, therefore, only increase as endoscopic techniques are adapted to meet the ever-more challenged diagnostic and therapeutic device needs.
The cold disposable biopsy forceps market is segmented into hospitals, pathology laboratories etc. Moreover, advancements in ergonomic designs, precision cutting, and sample retrieval technology are also contributing to the growth of the market. The shift toward minimally invasive diagnostic procedures is also driving demand.
Market Share Analysis by Key Players
| Company/Organization Name | Estimated Market Share (%) |
|---|---|
| Boston Scientific Corporation | 20-24% |
| Olympus Corporation | 16-20% |
| Cook Medical | 12-16% |
| ConMed Corporation | 10-14% |
| Medline Industries, Inc. | 8-12% |
| Others | 22-28% |
| Company/Organization Name | Key Offerings/Activities |
|---|---|
| Boston Scientific Corporation | Offers Radial Jaw™ Cold Disposable Biopsy Forceps designed for precise tissue sampling with reduced trauma. |
| Olympus Corporation | Develops EndoJaw™ Disposable Biopsy Forceps with high-precision cutting and easy maneuverability. |
| Cook Medical | Provides single-use biopsy forceps with rigid and flexible cup designs for enhanced tissue acquisition. |
| ConMed Corporation | Specializes in cold disposable biopsy forceps for gastrointestinal and pulmonary endoscopic procedures. |
| Medline Industries, Inc. | Manufactures cost-effective, sterile biopsy forceps with a focus on safety and infection control. |
Key Market Insights
Boston Scientific Corporation (20-24%)
Boston Scientific leads the cold disposable biopsy forceps market with its Radial Jaw™ forceps, which offer optimal sample retrieval, reduced mucosal trauma, and high flexibility for endoscopic tissue biopsy procedures.
Olympus Corporation (16-20%)
Olympus is a major player with its EndoJaw™ series, designed for enhanced maneuverability and precise cutting performance in gastrointestinal endoscopy and pulmonary diagnostics.
Cook Medical (12-16%)
Cook Medical provides ergonomic, single-use biopsy forceps that ensure reliable sample collection and low-risk biopsy procedures. The company focuses on customized forceps designs for various endoscopic applications.
ConMed Corporation (10-14%)
ConMed specializes in cold disposable biopsy forceps for pulmonary and gastrointestinal procedures, integrating precision-cutting technology and contamination-free design.
Medline Industries, Inc. (8-12%)
Medline manufactures cost-effective biopsy forceps that focus on infection prevention and affordability for hospitals, clinics, and ambulatory surgery centers.
Other Key Players (22-28% Combined)
Several emerging and regional players are contributing to market growth with affordable and innovative biopsy forceps solutions, including:
The overall market size for cold disposable biopsy forceps market was USD 742.9 million in 2025.
The cold disposable biopsy forceps market is expected to reach USD 1,574.4 million in 2035.
The growth of the Cold Disposable Biopsy Forceps market will be driven by increasing demand for minimally invasive diagnostic procedures, advancements in endoscopic biopsy technologies, and rising adoption of single-use medical devices for infection control and patient safety.
The top 5 countries which drives the development of cold disposable biopsy forceps market are USA, European Union, Japan, South Korea and UK.
1.8mm biopsy forceps to command significant share over the assessment period.
Glaucoma Treatment Market Overview – Trends & Forecast 2025 to 2035
Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market - Growth & Forecast 2025 to 2035
3D Printing Dental Devices Market Growth - Trends & Forecast 2025 to 2035
3D Printed Hip and Knee Implants Market Growth - Trends & Forecast 2025 to 2035
Idiopathic Thrombocytopenic Purpura Therapeutics Market Growth - Trends & Forecast 2025 to 2035
Teleradiology Services Market Growth - Trends & Forecast 2025 to 2035
Cold Disposable Biopsy Forceps Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
